BerGenBio

0 followers


BerGenBio: Developing first-in-class AXL inhibitors for aggressive diseases, including advanced, treatment resistant cancers

Industries

Headquarters

Bergen, Norway

Employees

11-50

Links

Org chart

Gayle Mills
Chief Business Officer
Cristina Oliva
Chief Medical Officer